In support of our study, recent work has shown that both S100A4 and MMP9 are upregulated in patient-derived lung cancer tissues and positively correlate with each other [23], further implicating the importance of S100A4/MMP9 signaling in lung cancer progression. This evidence concerns the gene MMP9 and lung cancer.